B ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted missile drug aims to wipe out last traces of leukemia
Disease control OngoingThis study is testing a targeted drug called inotuzumab ozogamicin for adults with B-cell acute lymphoblastic leukemia (ALL) who are in remission but still have tiny amounts of cancer cells detectable by sensitive tests. The drug is designed to seek out and destroy these remainin…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Major trial tests new drug combos for tough childhood leukemia
Disease control OngoingThis large study aims to find the best combination of chemotherapy drugs to control a high-risk type of childhood blood cancer called B-cell acute lymphoblastic leukemia (B-ALL). It enrolled nearly 6,000 children and young adults to test different treatment approaches, including …
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Major trial aims to boost cure rates for Kids' cancer
Disease control OngoingThis large study is testing if adding a targeted immunotherapy drug called blinatumomab to standard chemotherapy works better for children and young adults with newly diagnosed B-cell leukemia or lymphoma, including those with Down syndrome. It aims to see if this combination hel…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New immune therapy trial aims to target tough leukemia
Disease control OngoingThis early-stage study is testing the safety and side effects of a new type of immune cell therapy for adults with B-cell acute lymphoblastic leukemia that has come back or hasn't responded to other treatments. The therapy involves genetically modifying a patient's own immune cel…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for seniors battling aggressive blood cancer
Disease control OngoingThis study is testing two different treatment plans for adults aged 65 and older with a type of blood cancer called acute lymphoblastic leukemia (ALL). One plan combines an immunotherapy drug (blinatumomab) with standard chemotherapy. The other plan combines a targeted drug (dasa…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Engineered immune cells unleashed to battle tough leukemia
Disease control OngoingThis early-stage study is testing a new type of cell therapy for adults with a high-risk or returning form of acute lymphoblastic leukemia (ALL). Doctors take a patient's own immune cells, modify them in a lab to better target cancer, and infuse them back after a short course of …
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Major trial seeks gentler, effective leukemia treatment for kids
Disease control OngoingThis trial is for children and young adults with a specific, aggressive type of leukemia (Ph+ ALL). It tests whether a standard chemotherapy regimen works as well as a stronger one when both are given with the targeted drug imatinib, aiming to maintain high cure rates while reduc…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for young adults battling leukemia: major trial tests promising drug combo
Disease control TerminatedThis large, Phase 3 trial aims to see if adding a targeted drug called inotuzumab ozogamicin to standard chemotherapy works better for young adults (ages 18-39) newly diagnosed with a fast-growing blood cancer called B-cell acute lymphoblastic leukemia (ALL). The main goal is to …
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC